The post Blocery (BLY) A “Farm-To-Table” Approach appeared on BitcoinEthereumNews.com. Published: Jan 05, 2026 at 15:26 Blocery (BLY) is a blockchain-based projectThe post Blocery (BLY) A “Farm-To-Table” Approach appeared on BitcoinEthereumNews.com. Published: Jan 05, 2026 at 15:26 Blocery (BLY) is a blockchain-based project

Blocery (BLY) A “Farm-To-Table” Approach

Published: Jan 05, 2026 at 15:26

Blocery (BLY) is a blockchain-based project that focuses on utilizing blockchain technology and smart contracts to enhance transparency, traceability, and efficiency within the food supply chain.


It leverages blockchain technology to provide a transparent and traceable supply chain for agricultural and food products. This allows consumers to verify the origin and quality of the products they purchase.


Blocery’s concept is often described as a “farm-to-table” approach. It ensures that the journey of food products, from the farm to the consumer’s table, is recorded on the blockchain, allowing for real-time monitoring and transparency.


Smart contracts


Smart contracts play a central role in the Blocery ecosystem. They enable automated, trustless transactions between participants in the supply chain. Payments, deliveries, and quality assurance can all be governed by these contracts.

BLY Token


The BLY token is the native cryptocurrency of the Blocery platform. It serves various purposes, including payment for services, rewarding participants, and facilitating transactions within the ecosystem.


Blocery primarily targets the Korean market, with partnerships and collaborations with local agricultural and food producers.


Disclaimer. This article is for informational purposes only and should not be viewed as an endorsement by Coinidol.com. The data provided is collected by the author and is not sponsored by any company or token developer. They are not a recommendation to buy or sell cryptocurrency. Readers should do their research before investing in funds.


Expert in finance, blockchain, NFT, metaverse, and web3 writer with great technical research proficiency and over 15 years of experience.

Source: https://coinidol.com/blocery-bly-token/

Market Opportunity
Harvest Finance Logo
Harvest Finance Price(FARM)
$12.35
$12.35$12.35
-0.72%
USD
Harvest Finance (FARM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26